Results for tag: "Asmanex"

Asmanex is a brand of asthma drug, developed by Merck & Co., Inc. It is a corticosteroid, used to reduce inflammation in the airways of people with asthma. Asmanex is available in two forms: a dry powder inhaler and a metered-dose inhaler. The dry powder inhaler is used to prevent asthma symptoms, while the metered-dose inhaler is used to treat asthma symptoms. Asmanex is used to treat both adults and children over the age of four. Asmanex is part of a larger market of asthma drugs, which includes other corticosteroids, long-acting beta agonists, leukotriene modifiers, and combination inhalers. These drugs are used to treat and prevent asthma symptoms, and to reduce the risk of asthma attacks. The Asmanex market includes companies such as Merck & Co., Inc., GlaxoSmithKline, Novartis, and Boehringer Ingelheim. These companies produce and market a variety of asthma drugs, including Asmanex. Show Less Read more